To show the role of downstream complement components such as C5 or C5a-C5aR axis in CIA, administration of anti-C5 inhibitory (BB5.1) antibody was used and was found to both prevent the initiation and decrease the severity of arthritis (219, 241). Here, C5 is linked to arthritic joint disease.